Currently viewing the tag: "securities regulation"

The Rise of Real Estate Crowdinvesting

On October 9, 2014 By Christopher Borns

The use of crowdfunding has provided a welcome boost to the sluggish economy of recent years. Crowdfunding, according to Merriam-Webster, is “the practice of soliciting financial contributions from a large number of people[,] especially from the online community.”  Crowdfunding campaigns, thus, do not focus on soliciting one or two major [...]

Continue Reading

On June 23th, the Supreme Court handed down one of the most highly anticipated securities litigation opinions in recent memory. Halliburton II brought the fraud-on-the-market theory, the linchpin of securities class actions, squarely in front of the Court. For months, excerpts from various other Court opinions suggested the theory was ripe [...]

Continue Reading

The Supreme Court Takes on Big Pharma

On April 6, 2011 By Sarah Duncan

In a number of recent cases, the Supreme Court has taken on the pharmaceutical industry, resulting in decisions with important implications for plaintiffs, drug manufacturers, and Americans who purchase pharmaceutical drugs.

On February 22, the Court held in Bruesewitz et al. v. Wyeth Inc. that the National Childhood Vaccine Injury Act of 1986, [...]

Continue Reading